2m 2m 2m 2m 2m 2m 2m
AVALYN PHARMA (AVLN)
NASDAQ
$27.26+$0.005 (+0.02%)
Price as of Oct 22, 2026 4:25 PM EDT- $1.1BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
AVALYN PHARMA (AVLN)
$27.26+$0.005 (+0.02%)
AVLN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.25 | ||
Change | +$0.48 (+1.95%) | ||
Open | $25.12 | ||
High | $27.57 | ||
Low | $25.10 | ||
Previous Close | $25.11 | ||
Volume | 286,743 | ||
30-Day Average Volume | 302,244 | ||
1-Week Change | 5.99% | ||
1-Month Change | -20.59% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.3M | ||
Total Assets | $425.4M | ||
Market Cap | $1.1B | ||
Enterprise Value | $878.8M | ||
Period: QTR TTM FY | |||
Revenue | $2.7M | ||
Net Income | -$28.9M | ||
Free Cash Flow | -$26.3M | ||
EBIT | -$28.6M | ||
EBITDA | -$28.5M | ||
Net Working Capital | $347.2M | ||
EPS | -$0.98 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | 326 | ||
P/B | 3 | ||
P/E | -26 | ||
PEG | -0 | ||
Price/Free Cash Flow | -42 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 3 | ||
Last Split Date | 09/25/2007 | ||